Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor
Toshio Nishimura(Hyogo Prefectural Cancer Center), Takashi Minegishi(Gunma University)
Cited by 21
Related Papers
Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy
|Oncology Reports|2006|57
Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma
|British Journal of Cancer|2000|36
HOX cofactors expression and regulation in the human ovary
|Reproductive Biology and Endocrinology|2008|21